These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 20049829)

  • 1. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
    Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticulate radiolabelled quinolines detect amyloid plaques in mouse models of Alzheimer's disease.
    Roney CA; Arora V; Kulkarni PV; Antich PP; Bonte FJ
    Int J Alzheimers Dis; 2010 Jan; 2009():. PubMed ID: 20721294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease.
    Opazo C; Luza S; Villemagne VL; Volitakis I; Rowe C; Barnham KJ; Strozyk D; Masters CL; Cherny RA; Bush AI
    Aging Cell; 2006 Feb; 5(1):69-79. PubMed ID: 16441845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
    Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
    Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.
    Kandimalla KK; Curran GL; Holasek SS; Gilles EJ; Wengenack TM; Poduslo JF
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1370-8. PubMed ID: 15743932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
    Joshi SA; Chavhan SS; Sawant KK
    Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
    Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
    J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.
    Roney C; Kulkarni P; Arora V; Antich P; Bonte F; Wu A; Mallikarjuana NN; Manohar S; Liang HF; Kulkarni AR; Sung HW; Sairam M; Aminabhavi TM
    J Control Release; 2005 Nov; 108(2-3):193-214. PubMed ID: 16246446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Introduction to and general remarks on molecular imaging].
    Fukuda H; Okamura N
    Brain Nerve; 2007 Mar; 59(3):203-7. PubMed ID: 17370645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo labelling of hippocampal beta-amyloid in triple-transgenic mice with a fluorescent acetylcholinesterase inhibitor released from nanoparticles.
    Härtig W; Kacza J; Paulke BR; Grosche J; Bauer U; Hoffmann A; Elsinghorst PW; Gütschow M
    Eur J Neurosci; 2010 Jan; 31(1):99-109. PubMed ID: 20092557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques.
    Li Q; Min J; Ahn YH; Namm J; Kim EM; Lui R; Kim HY; Ji Y; Wu H; Wisniewski T; Chang YT
    Chembiochem; 2007 Sep; 8(14):1679-87. PubMed ID: 17705341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diphenylpropynone derivatives as probes for imaging β-amyloid plaques in Alzheimer's brains.
    Ono M; Watanabe H; Watanabe R; Haratake M; Nakayama M; Saji H
    Bioorg Med Chem Lett; 2011 Jan; 21(1):117-20. PubMed ID: 21145738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model.
    Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
    Mol Pharm; 2010 Jun; 7(3):815-25. PubMed ID: 20230014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.
    Adlard PA; Cherny RA; Finkelstein DI; Gautier E; Robb E; Cortes M; Volitakis I; Liu X; Smith JP; Perez K; Laughton K; Li QX; Charman SA; Nicolazzo JA; Wilkins S; Deleva K; Lynch T; Kok G; Ritchie CW; Tanzi RE; Cappai R; Masters CL; Barnham KJ; Bush AI
    Neuron; 2008 Jul; 59(1):43-55. PubMed ID: 18614028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 18F-labeled benzofuran derivatives with improved properties for positron emission tomography (PET) imaging of β-amyloid plaques in Alzheimer's brains.
    Ono M; Cheng Y; Kimura H; Cui M; Kagawa S; Nishii R; Saji H
    J Med Chem; 2011 Apr; 54(8):2971-9. PubMed ID: 21428407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid imaging: from benchtop to bedside.
    Wu C; Pike VW; Wang Y
    Curr Top Dev Biol; 2005; 70():171-213. PubMed ID: 16338342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.